中国输血杂志2023，Vol.36Issue(11)：971-977,7.DOI:10.13303/j.cjbt.issn.1004-549x.2023.11.001
ABO血型不合异基因造血干细胞移植受者血型检测与血液成分输注专家共识
Expert consensus on recipient blood type test and blood component transfusion after ABO-incompatibility hemato-poietic stem cell transplantation
ABOi-HSCT血型检测与血液成分输注专家共识编写组 1李小飞 1马春娅 1侯瑞琴 1于洋 1向东 1付丹晖1
作者信息
摘要
Abstract
At present,ABO-incompatibility hematopoietic stem cell transplantation(ABOi-HSCT)accounts for 30%～50% of the total HSCT,and is no longer a major obstacle to HSCT.Transfusion therapy is an important treatment for HSCT patients during transplantation,and correct blood typing and blood selection of blood component are particularly important.For patients with ABOi-HSCT,one of the challenging issues for laboratory technician is to complete ABO blood group testing and report before,during,and after ABOi-HSCT,as well as the selection of blood components that balance transfusion safety and efficacy.This consensus was jointly discussed by domestic experts in transfusion medicine and hematology in China,and 7 recommended opinions were extracted to further standardize the blood typing and blood component infusion strategies for ABOi-HSCT patients,provide technical support for standardized blood typing reports and accurate blood component infusion for HSCT patients,and continuously improve the safety and efficacy of blood transfusion.关键词
ABO血型不合/造血干细胞移植/血型/输血/专家共识Key words
ABO-incompatibility/hematopoietic stem cell transplantation(HSCT)/blood type/blood transfusion/ex-pert consensus分类
临床医学引用本文复制引用
ABOi-HSCT血型检测与血液成分输注专家共识编写组,李小飞,马春娅,侯瑞琴,于洋,向东,付丹晖..ABO血型不合异基因造血干细胞移植受者血型检测与血液成分输注专家共识[J].中国输血杂志,2023,36(11):971-977,7.
